Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia

  • Vega-Garcia, Nerea
  • Benito, Rocío
  • Esperanza-Cebollada, Elena
  • Llop, Marta
  • Robledo, Cristina
  • Vicente-Garcés, Clara
  • Alonso, Javier
  • Barragan, Eva
  • Fernández, Guerau
  • Hernández-Sánchez, Jesús M
  • Martín-Izquierdo, Marta
  • Maynou, Joan
  • Minguela, Alfredo
  • Montaño, Adrián
  • Ortega, Margarita
  • Torrebadell, Montserrat
  • Cervera, José
  • Sánchez, Joaquín
  • Jiménez-Velasco, Antonio
  • Riesco, Susana
  • Hernández-Rivas, Jesús M
  • Lassaletta, Álvaro
  • Fernández, José María
  • Rives, Susana
  • Dapena, José Luis
  • Ramírez, Manuel
  • Camós, Mireia
  • Spanish Society of Pediatric Hematology and Oncology (SEHOP). Group of Leukemia
The development of Next-Generation Sequencing (NGS) has provided useful diagnostic, prognostic, and therapeutic strategies for individualized management of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) patients. Consequently, NGS is rapidly being established in clinical practice. However, the technology's complexity, bioinformatics analysis, and the different available options difficult a broad consensus between different laboratories in its daily routine introduction. This collaborative study among Spanish centers was aimed to assess the feasibility, pros, and cons of our customized panel and other commercial alternatives of NGS-targeted approaches. The custom panel was tested in three different sequencing centers. We used the same samples to assess other commercial panels (OncomineTM Childhood Cancer Research Assay; Archer®FusionPlex® ALL, and Human Comprehensive Cancer Panel GeneRead Panel v2®). Overall, the panels showed a good performance in different centers and platforms, but each NGS approach presented some issues, as well as pros and cons. Moreover, a previous consensus on the analysis and reporting following international guidelines would be preferable to improve the concordance in results among centers. Our study shows the challenges posed by NGS methodology and the need to consider several aspects of the chosen NGS-targeted approach and reach a consensus before implementing it in daily practice.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia

  • Vega-Garcia, Nerea
  • Benito, Rocío|||0000-0001-9781-4198
  • Esperanza-Cebollada, Elena|||0000-0001-5451-0370
  • Llop, Marta
  • Robledo, Cristina|||0000-0003-0445-3210
  • Vicente-Garcés, Clara|||0000-0002-2556-043X
  • Alonso, Javier|||0000-0002-6287-8391
  • Barragán, Eva
  • Fernández, Guerau
  • Hernández-Sánchez, Jesús M.
  • Martín-Izquierdo, Marta
  • Maynou, Joan
  • Minguela, Alfredo|||0000-0003-2472-5893
  • Montaño, Adrián|||0000-0002-3178-6726
  • Ortega, Margarita
  • Torrebadell, Montserrat
  • Cervera, José|||0000-0001-8252-1106
  • Sánchez, Joaquín
  • Jiménez-Velasco, Antonio|||0000-0001-6421-7872
  • Riesco, Susana
  • Hernández Rivas, Jesús María|||0000-0002-9661-9371
  • Lassaletta, Álvaro|||0000-0003-2881-1473
  • Fernández, José María
  • Rives, Susana|||0000-0002-5658-1831
  • Dapena, José Luis|||0000-0002-6711-7479
  • Ramírez, Manuel|||0000-0003-0332-6973
  • Camós, Mireia|||0000-0003-3658-7942
The development of Next-Generation Sequencing (NGS) has provided useful diagnostic, prognostic, and therapeutic strategies for individualized management of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) patients. Consequently, NGS is rapidly being established in clinical practice. However, the technology's complexity, bioinformatics analysis, and the different available options difficult a broad consensus between different laboratories in its daily routine introduction. This collaborative study among Spanish centers was aimed to assess the feasibility, pros, and cons of our customized panel and other commercial alternatives of NGS-targeted approaches. The custom panel was tested in three different sequencing centers. We used the same samples to assess other commercial panels (Oncomine TM Childhood Cancer Research Assay; Archer ® FusionPlex ® ALL, and Human Comprehensive Cancer Panel GeneRead Panel v2 ®). Overall, the panels showed a good performance in different centers and platforms, but each NGS approach presented some issues, as well as pros and cons. Moreover, a previous consensus on the analysis and reporting following international guidelines would be preferable to improve the concordance in results among centers. Our study shows the challenges posed by NGS methodology and the need to consider several aspects of the chosen NGS-targeted approach and reach a consensus before implementing it in daily practice.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Focal Adhesion Genes Refine the Intermediate-Risk Cytogenetic Classification of Acute Myeloid Leukemia

  • Pallarès, Victor|||0000-0002-9851-0345
  • Hoyos Colell, Montserrat|||0000-0002-1911-1734
  • Chillón, M. Carmen|||0000-0003-1624-6059
  • Barragán, Eva
  • Prieto Conde, M. Isabel
  • Llop, Marta
  • Falgàs, Aïda|||0000-0002-5040-2265
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Montesinos, Pau|||0000-0002-3275-5593
  • Nomdedeu Guinot, Jose Francisco|||0000-0003-3399-346X
  • Brunet, Salut|||0000-0003-0491-1672
  • Sanz, Miguel A.|||0000-0003-1489-1177
  • González-Díaz, Marcos
  • Sierra, Jorge|||0000-0002-7966-0356
  • Mangues, Ramon|||0000-0003-2661-9525
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
In recent years, several attempts have been made to identify novel prognostic markers in patients with intermediate-risk acute myeloid leukemia (IR-AML), to implement risk-adapted strategies. The non-receptor tyrosine kinases are proteins involved in regulation of cell growth, adhesion, migration and apoptosis. They associate with metastatic dissemination in solid tumors and poor prognosis. However, their role in haematological malignancies has been scarcely studied. We hypothesized that PTK2/FAK, PTK2B/PYK2, LYN or SRC could be new prognostic markers in IR-AML. We assessed PTK2, PTK2B, LYN and SRC gene expression in a cohort of 324 patients, adults up to the age of 70, classified in the IR-AML cytogenetic group. Univariate and multivariate analyses showed that PTK2B, LYN and PTK2 gene expression are independent prognostic factors in IR-AML patients. PTK2B and LYN identify a patient subgroup with good prognosis within the cohort with non-favorable FLT3/NPM1 combined mutations. In contrast, PTK2 identifies a patient subgroup with poor prognosis within the worst prognosis cohort who display non-favorable FLT3/NPM1 combined mutations and underexpression of PTK2B or LYN. The combined use of these markers can refine the highly heterogeneous intermediate-risk subgroup of AML patients, and allow the development of risk-adapted post-remission chemotherapy protocols to improve their response to treatment.
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Construction of Titanasiloxanes by Incorporation of Silanols to the Metal Oxide Model [{Ti(η5-C5Me5)(μ-O)}3(μ3-CR)]: DFT Elucidation of the Reaction Mechanism

  • Carbó, Jorge J.
  • González del Moral, Octavio
  • Martín Alonso, Avelino|||0000-0002-9776-9670
  • Mena Montoro, Miguel|||0000-0001-7456-1212
  • Poblet Rius, Josep María
  • Santamaría Angulo, Cristina|||0000-0003-2410-961X
A family of novel titanasiloxanes containing the structural unit {[Ti(h5-C5Me5)O]3} were synthesized by hydron-transfer processes involving reactions with equimolecular amounts of m3-alkylidyne derivatives [{Ti(h5-C5Me5)(m-O)}3(m3-CR)] (R=H (1), Me (2)) and monosilanols, R3?Si(OH), silanediols, R2?Si(OH)2, and the silanetriol tBuSi(OH)3. Treatment of 1 and 2 with triorganosilanols (R?=Ph, iPr) in hexane affords the new metallasiloxane derivatives [{Ti(h5-C5Me5)(m-O)}3(m-CHR)(OSiR3?)] (R=H , R?=Ph (3), iPr (4); R=Me, R?=Ph (5), iPr (6)). Analogous reactions with silanediols, (R?= Ph, iPr), give the cyclic titanasiloxanes [{Ti(h5-C5Me5)(m-O)}3(m-O2SiR?2)(R)] (R=Me, R?=Ph (7), iPr (8); R=Et, R?=Ph (9), iPr (10)). Utilization of tBuSi(OH)3 with 1 or 2 at room temperature produces the intermediate complexes [{Ti(h5-C5Me5) (m-O)}3(m-O2Si(OH)tBu)(R)] (R=Me (11), Et(12)). Further heating of solutions of 11 or 12 affords the same compound with an adamantanoid structure, [{Ti-(h5-C5Me5)(m-O)}3(m-O3SitBu)] (13) and methane or ethane elimination, respectively. The X-ray crystal structures of 3, 4, 6, 8, 10, 12, and 13 have been determined. To gain an insight into the mechanism of these reactions, DFT calculations have been performed on the incorporation of monosilanols to the model complex [{Ti(h5-C5H5)(m-O)}3-(m3-CMe)] (2H). The proposed mechanism consists of three steps: 1) hydron transfer from the silanol to one of the oxygen atoms of the Ti3O3 ring, forming a titanasiloxane; 2) intramolecular hydron migration to the alkylidyne moiety; and 3) a m-alkylidene ligand rotation to give the final product., Ministerio de Ciencia y Tecnología, Comunidad de Madrid, Universidad de Alcalá, Generalitat de Catalunya
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Yttrium and Erbium Halide Complexes with [{Ti(η5-C5Me5)(μ-NH)}3(μ3-N)] as a Neutral Tridentate Ligand

  • Caballo González, Jorge
  • García Castro, María
  • Martín Alonso, Avelino|||0000-0002-9776-9670
  • Mena Montoro, Miguel|||0000-0001-7456-1212
  • Pérez Redondo, Adrián|||0000-0002-0086-8825
  • Yélamos Sánchez, Carlos|||0000-0003-0425-4799
Treatment of [{TiCp*(mu-NH)}(3)(mu(3)-N)] (1; Cp* = eta(5)-C5Me5) with yttrium and erbium halide complexes [MCl3(THF)(3.5)] and [MCpCl2(THF)(3)] (Cp = eta(5)-C5H5) gives cube-type adducts [Cl3M{(mu(3)-NH)(3)Ti3Cp*(3)(mu(3)-N)}] and [CPCl2M{(mu(3)-NH)(3)Ti3Cp*(3)(mu(3)-N)}]. An analogous reaction of 1 with [{MCp2Cl}(2)] in toluene affords [Cp3M(mu-Cl)ClCpM{(mu(3)-NH)(3)Ti3Cp*(3)(mu(3)-N)}] (M = Y, Er)., Ministerio de Educación y Ciencia, Comunidad de Madrid, Universidad de Alcalá
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Lewis Base Behavior of Bridging Nitrido Ligands of Titanium Polynuclear Complexes

  • Carbó, Jorge J.
  • Martínez Espada, Noelia
  • Mena Montoro, Miguel|||0000-0001-7456-1212
  • González Mosquera, Marta Elena|||0000-0003-2248-3050
  • Poblet Rius, Josep María
  • Yélamos Sánchez, Carlos|||0000-0003-0425-4799
The Lewis base behavior of mu(3)-nitrido ligands of the polynuclear titanium complexes [{Ti(eta(5)-C(5)Me(5))(mu-NH)}(3)(mu(3)-N)] (1) and [{Ti(eta(5)-C(5)Me(5))}(4)-(mu(3)-N)(4)] (2) to MX Lewis acids has been observed for the first time. Complex 1 entraps one equivalent of copper(I) halide or copper(I) trifluorornethanesulfonate through the basal NH imido groups to give cube-type adducts [XCu{(mu(3)-NH)(3)Ti(3)(eta(5)-C(5)Me(5))(3)(mu(3)-N)}] (X=Cl (3), Br (4), I (5), OSO(2)CF(3) (6)). However, the treatment of 1 with an excess (>= 2 equiv) of copper reagents afforded complexes [XCu{(mu(3)-NH)(3)Ti(3)(eta(5)-C(5)Me(5))(3)(mu(4)-N)(CuX)}] (X=Cl (7), Br (8), I (9) OSO(2)CF(3) (10)) by incorporation of an additional CuX fragment Lit the mu(3)-N nitrido apical group. Similarly, the tetranuclear cube-type nitrido derivative 2 is capable of incorporating one, two, or up to three CuX units at the mu(3)-N ligands to give complexes [{Ti(eta(5)-C(5)Me(5))}(4)(mu(3)-N)(4-n)-{(mu(4)-N)CuX}(n)] (X=Br (11), n=1; X=Cl (12) n=2; X=OSO(2)CF(3) (13), n=3). Compound 2 also reacts with silver(I) trifluoromethanesulfortate (>= 1 equiv) to give the adduct [{Ti(eta(5)-C(5)Me(5))}(4)(mu(3)-N)(3){(mu(4)-N)AgOSO(2)CF(3)}] (14). X-ray crystal structure determinations have been performed for complexes 8-13. Density functional theory calculations have been carried out to understand the nature and strength of the interactions of [{Ti(eta(5)-C(5)H(5))(mu-NH)}(3)(mu(3)-N)] (1') and [{Ti(eta(5)-C(5)H(5))}(4)-(mu(3)-N)(4)] (2') model complexes with copper and silver MX fragments. Although coordination through the three basal NH imido groups is thermodynamically preferred in the case of V, in both complexes the mu(3)-nitrido groups act as two-electron donor Lewis bases to the appropriate Lewis acids., Ministerio de Educación y Ciencia, Comunidad de Madrid, Universidad de Alcalá, Ministerio de Ciencia e Innovación, Comisión Asesora de Investigación Científica y Técnica
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Group 13 Organoderivatives Supported on a Metallic Oxide Model.

  • González del Moral, Octavio
  • Hernán-Gómez Robledo, Alberto|||0000-0001-7020-0196
  • Martín Alonso, Avelino|||0000-0002-9776-9670
  • Mena Montoro, Miguel|||0000-0001-7456-1212
  • Santamaría Angulo, Cristina|||0000-0003-2410-961X
The [{TiCp*(m-O)}3(m3?CH)] (1) metalloligand, (Cp* = h5-C5Me5), coordinates in a 1 : 1 ratio to [AlMe3] or 9BBN to give [{Me3Al}{(m3-O)(m-O)2(TiCp*)3(m3-CH)}] (2) or [{(C8H14)B}(m-H){(m3-O)(m-O)2(TiCp*)3(m3-CH)}] (4), respectively, partial hydrolysis of 2 leads to the new hydroxo-aluminium derivative [{MeAl}{(m-OH)(m3-O)}2{(m-O)2(TiCp*)3(m3-CH)}2] (3)., Ministerio de Ciencia y Tecnología, Universidad de Alcalá, Comunidad de Madrid